Skip to main content

WNK lysine deficient protein kinase 4

The WNK4 gene provides instructions for making a protein that plays a role in blood pressure regulation by helping control the amount of sodium and potassium in the body. The WNK4 protein acts as a kinase, which is an enzyme that changes the activity of other proteins by adding a cluster of oxygen and phosphorus atoms (a phosphate group) at specific positions.

Video picks for Genes
Video library

Normal function

The WNK4 gene provides instructions for making a protein that plays a role in blood pressure regulation by helping control the amount of sodium and potassium in the body. The WNK4 protein acts as a kinase, which is an enzyme that changes the activity of other proteins by adding a cluster of oxygen and phosphorus atoms (a phosphate group) at specific positions.

The WNK4 protein regulates channels in the cell membrane that control the transport of sodium or potassium into and out of cells, which occurs primarily in the kidneys. Sodium channels help transport sodium into specialized kidney cells, which then transfer it into the blood. This transfer helps keep sodium in the body through a process called reabsorption. Potassium channels handle excess potassium that has been transferred from the blood into the kidney cells. The channels transport the potassium out of the cells in a process called secretion, so that it can be removed from the body in the urine. The WNK4 protein is able to promote sodium reabsorption and block potassium secretion. Depending on conditions in the cell, the WNK4 protein is also able to block (inhibit) sodium reabsorption.

Conditions referring to this gene or chromosome

Other names

PHA2B

PRKWNK4

protein kinase lysine-deficient 4

protein kinase with no lysine 4

serine/threonine-protein kinase WNK4

WNK4_HUMAN

Patient picks for Genes

Related patient information and medicines

Glycogen storage disorders

Patient information leaflet

Glycogen storage disorders

Glycogen storage disorders are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Muscular dystrophy

Patient information leaflet

Muscular dystrophy

What is muscular dystrophy. Muscular dystrophy (MD) is the name given to a group of disorders which cause progressive muscle weakness (meaning it gets worse over time). There are many different types of MD. Also, if a child has delayed mo... MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase.

Mouth cancer

Patient information leaflet

Mouth cancer

Epidermal growth factor receptor monoclonal antibody (EGFR mAb) is one form of targeted therapy. Cetuximab is an EGFR mAb. Tyrosine kinase inhibitors (TKIs) are another. Immunotherapy is treatment that aims to boost the body's own immune system to destroy the cancer cells. It is also sometimes called biological therapy: Recombinant interleukin.

Primary liver cancer

Patient information leaflet

Primary liver cancer

It is not likely to be curative for primary liver cancer but may shrink the tumour down to slow the progression of the disease. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine called a multi-targeted kinase inhibitor. It interferes with the growth of cancer cells. Research has.

Liver function tests

Patient information leaflet

Liver function tests

This means that the cause of liver strain or damage can be diagnosed and, often, reversed. Liver function tests are also used for monitoring in cases of known liver inflammation, injury or disease. What are the main liver function tests. The usual liver function tests typically include the following: Bilirubin. Albumin. Total protein. Transferases.

Mastocytosis and mast cell disorders

Patient information leaflet

Mastocytosis and mast cell disorders

Triggers for mastocytosis symptoms Although not strictly speaking the cause of mastocytosis,. If the condition is severe, surgery to remove the spleen (splenectomy), medi... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 8 May 2023 | Latest version
  • 1 Mar 2016 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.